Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Maxime, Herve"'
Publikováno v:
Nutrients, Vol 16, Iss 6, p 887 (2024)
A balanced microbiota—microorganisms that live in the gut—is crucial in the early years of a child’s life, while dysbiosis—altered microbiota—has been linked to the development of various diseases. Probiotics, such as Alkalihalobacillus cla
Externí odkaz:
https://doaj.org/article/91902d4e6af244d0b0619e9caef1f796
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
For several thousand years (~4000) Boswellia serrata and Curcuma longa have been used in Aryuvedic medicine for treatment of various illnesses, including asthma, peptic ulcers, and rheumatoid arthritis, all of which are mediated through pathways asso
Externí odkaz:
https://doaj.org/article/a780c5812a8e46ba9e1dd1312aa157cc
Publikováno v:
Pain Management. 13:61-69
COVID-19, an infection caused by SARS-CoV-2, had a devastating impact on people's lives. The pandemic placed a heavy burden on healthcare systems and impacted the care of patients, including those with pain. This narrative review aims to highlight th
Autor:
Flora Gouzerh, LAURENT DORMONT, Bruno Buatois, Maxime Herve, MAICOL MANCINI, ANTONIO MARAVER, FREDERIC THOMAS, GUILA GANEM
Publikováno v:
SSRN Electronic Journal.
Autor:
Luis R. Camacho, Srinivasa P. S. Rao, Christian G. Noble, Ravinder Reddy Kondreddi, Thierry T. Diagana, Ujjini H. Manjunatha, Anne Goh, Maxime Herve, Paul W. Smith, Stefan Peukert, Pearly Shuyi Ng, Ngai Ling Ma
Publikováno v:
European Journal of Medicinal Chemistry. 106:144-156
Pyridone 1 was identified from a high-throughput cell-based phenotypic screen against Mycobacterium tuberculosis (Mtb) including multi-drug resistant tuberculosis (MDR-TB) as a novel anti-TB agent and subsequently optimized series using cell-based Mt
Autor:
Laura E. Via, Martin W. Bratschi, Soohee Hwang, Hui Ming Lim, Gerd Michel, Mamadou Daffé, Gek Huey Chua, Clifton E. Barry, Hyun-Kyung Kwak, Véronique Dartois, Anne K. Bendt, Marie-Antoinette Lanéelle, Guanghou Shui, Markus R. Wenk, Seokyong Eum, Ignasius A. Jappar, Ang Lay Teng Michelle, Maxime Herve, Jong-Soek Lee, Siti Zarina Zainul Rahim
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine; Vol 4
EMBO Molecular Medicine; Vol 4
Mycolic acids are attractive diagnostic markers for tuberculosis (TB) infection because they are bacteria-derived, contain information about bacterial species, modulate host–pathogen interactions and are chemically inert. Here, we present a novel a
Autor:
Rosa Catera, R. Hal Scofield, Lu Zhang, Sebastien Didier, Maxime Herve, Nicholas Chiorazzi, Helen Vlassara, Steven L. Allen, Charles C. Chu, Katerina Hatzi, Jonathan E. Kolitz, Yifang Chen, Gregg J. Silverman, Eric Meffre, Till Seiler, David Oscier, Kanti R. Rai
Publikováno v:
Molecular Medicine. 14:665-674
Chronic lymphocytic leukemia (CLL) represents the outgrowth of a CD5(+) B cell. Its etiology is unknown. The structure of membrane Ig on CLL cells of unrelated patients can be remarkably similar. Therefore, antigen binding and stimulation could contr
Autor:
Ujjini H. Manjunatha, Richard Glynne, John R. Walker, Bee Huat Tan, Paul W. Smith, Srinivasa P. S. Rao, Kelli Kuhen, Pearly Shuyi Ng, Christian G. Noble, Susan W. Barnes, Peter J. Tonge, Seow H. Ng, Suresh B. Lakshminarayana, Ng L. Ma, Ravinder Reddy Kondreddi, Francesca Blasco, Thierry T. Diagana, David Beer, Maxime Herve, Weixuan Yu, Luis R. Camacho
Publikováno v:
Science Translational Medicine. 7
New chemotherapeutic agents are urgently required to combat the global spread of multidrug-resistant tuberculosis (MDR-TB). The mycobacterial enoyl reductase InhA is one of the few clinically validated targets in tuberculosis drug discovery. We repor
Autor:
Maxime Herve, Bradley T. Messmer, Yen Shing Ng, Eric Meffre, Hedda Wardemann, Kai Xu, Nicholas Chiorazzi, Emilia Albesiano
Publikováno v:
Journal of Clinical Investigation. 115:1636-1643
B cell chronic lymphocytic leukemia (CLL) is a disease of expanding monoclonal B cells whose B cell receptor (BCR) mutational status defines 2 subgroups; patients with mutated BCRs have a more favorable prognosis than those with unmutated BCRs. CLL B